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ABSTRACT 
Low signal to noise ratios and limited imaging depths restrict the ability of optical-imaging modalities to 
detect and accurately quantify molecular emissions from tissue. Here, by using a scanning external X-
ray beam from a clinical linear accelerator to induce Cherenkov excitation of luminescence in tissue, we 
demonstrate in vivo mapping of the oxygenation of tumours at depths of several millimetres, with 
submillimetre resolution and nanomolar sensitivity. This was achieved by scanning thin sheets of the X-
ray beam orthogonally to the emission-detection plane, and detecting the signal via a time-gated CCD 
camera synchronized to the radiation pulse. We also show with experiments using phantoms and with 
simulations that the performance of Cherenkov-excited luminescence scanned imaging (CELSI) is 
limited by beam size, scan geometry, probe concentration, radiation dose and tissue depth. CELSI 
might provide the highest sensitivity and resolution in the optical imaging of molecular tracers in vivo. 
  
  
Introduction 
Optical luminescence is the dominant preclinical imaging modality for the molecular probing of cells and 
tissue physiology, both in vitro and in vivo  [1-3].  The sensitivity of optical detectors to small 
concentrations of molecular emitters and the ease of use of the detection technology make optical 
molecular imaging much more widely used than x-rays, ultrasound, nuclear medicine or magnetic 
resonance imaging (MRI). However, because of elastic scattering of light in tissue, the tissue depths 
accessible by optical imaging in vivo are fundamentally limited [4-6]. Although fluorescence and 
bioluminescence have been used extensively to elucidate intracellular signalling in vitro, their use in vivo 
is largely limited to bulk temporal kinetics, surface tissue imaging [7-9], or invasive/surgical 
measurements [7]. The inability to reconstruct the spatial origin of a detected photon generally limits non-
invasive in vivo luminescent molecular imaging, where high spatial resolution has never been achieved 
beyond microscopy.  Additionally, the decrease in signal intensity with depth into tissue is exponential, 
creating highly non-linear excitation during imaging, as illustrated in Figure 1(a). 
Here, Cherenkov excited luminescence scanned imaging (CELSI) [10, 11] was used to sense 
luminescent molecular probes deep within tissue, utilizing megavolt (MV) x-ray radiation, and adopting 
an orthogonal excitation geometry that allows scanning the region of interest, similarly to the way 
fluorescent light sheet microscopy works [12], as shown in Figure 1(b). As the illuminated area is 
consistently at a known distance from the detector, this geometry maximises the signal to noise ratio, 
which tends to be the dominant factor in quantitative imaging of thick and optically turbid samples. 
Importantly, Cherenkov light of organic molecules is based upon the electronic energy level of the 
excitation beam. Thus, with high MV x-ray sheet illumination, the spatial targeting of x-rays can be 
optimally combined with biological organic probes [9] already widely used in animals for other imaging 
modalities and is translatable to humans.  CELSI is intended as an optical imaging tool which can 
preserve the linearity of the emitted optical signal with depth, and not be overly affected by scatter 
dominance in tissue.  Further illustration of the value of CELSI relative to other imaging modalities can 
be seen in the Supplementary Data, Figure S.1.  The geometry used here is illustrated in Figure 1(c) and 
temporal and spatial parameters in Figure 1(d).  
 
Cherenkov light is generated in tissue from the scatter-induced secondary electrons produced 
from x-rays, here generated by a therapeutic MV linear accelerator (LINAC), that interact with the 
dielectric media. The spectrum of Cherenkov light is broadband, peaks in the ultraviolet (UV), and decays 
in intensity (I) with a wavelength dependence of l ~ 1/O2, shown in Figure 1(e). Luminescence of the probe 
is therefore excited only within the volume that is directly in the path of the scanning radiation beam, 
Figure 1(b), so that all luminescent signals detected by the intensified charge coupled device (ICCD) are 
considered as originating exclusively from within the pathway of the linear accelerator (LINAC) beam. 
This geometrical arrangement adopts some of the principles of directed excitation imaging tools, such as 
ultrasound, where depth-dependent attenuation correction can be applied to the data because of 
knowledge of the excitation or emission beam depth. The limiting factor remains the intensity attenuation 
with distance by diffusion scatter and absorption as the emitted light passes through the tissue. The 
luminescent probe used here Platinum Oxyphor G4 (PtG4) is optimized for oxygen sensing, with a 
luminescent lifetime in the range of 22-44 microseconds, and an emission wavelength in the near-infrared 
[13, 14], shown in Figure 1(e) & (f).  
 
Deep tissue Cherenkov excitation from ionizing radiation of isotopes can also excite molecular 
luminescence [15, 16], with the signal increasing proportionally to the emitted gamma ray energy. 
Similarly, radiation delivered by a medical LINAC generates Cherenkov emission within the treated tissue 
[17] and can be visualized for patient dosimetry studies [18], as well as excitation of molecular probes  
[19, 20].  This process can be utilized to excite fluorescent or phosphorescent probes in tissue to sense 
diagnostic molecular features, and has been demonstrated at low radiation doses [10], where high energy 
MV photons have the highest generation of Cherenkov, yet the lowest deposited dose level in tissue. The 
excitation light from Cherenkov is directed by the incident beam, and so the observation of emission need 
not be highly localized because the signal is backprojected along the line of the Cherenkov beam, and 
also enables attenuation correction to be readily applied to the signal, based upon the depth of the beam. 
Additionally, altering the orthogonal angle of the excitation beam to the collection plane allows some 
advantages in signal to background improvement, as used in thick tissue fluorescence microscopy[12, 
21]. This geometry makes CELSI’s approach to signal measurement much more useful for whole body 
imaging, as it eliminates the need to estimate the depth of the optical signal origin. 
 
 The aim of this work was to evaluate the potential for Cherenkov excited luminescence scanned 
imaging to directly sample partial pressure of oxygen (pO2) in vivo for mammalian tissue, estimating the 
spatial resolution, depth and probe concentration sensitivity bounds, and estimate the signal to 
background values available for realistic tumor imaging applications.  
  
Results 
Beam Size: By measuring total luminescence signal and considering prior information about position of 
the scanning beam, the distribution of optical signal along the direction of scanning can be recovered. In 
Figure 2(a)-(c), the possible beam geometries are illustrated, where the x-ray sheet can be shaped as a 
broad beam covering the entire tissue volume, as is commonly used in radiotherapy, or a 2 dimensional 
sheet of 5mm thickness, or a pencil beam, 5x5mm2, which can be raster scanned around the tissue. The 
benefit of a pencil beam would be the highest spatial resolution, in step sizes of 0.1mm, whereas the 
benefit of a broad sheet is the fast imaging acquisition. However, the choices here make a large impact 
on the image quality and signal strength.  In Figure 2(d) a broad homogenous phantom was imaged with 
a large square beam 100x100mm2, and then by a thin sheet beam, 5x100 mm2, and then a pencil beam, 
5x5mm2, as described in the Methods.  The phantom used had an embedded luminescent square 10x10 
mm2, at depth within it, to test for signal recovery, and the contrast to noise ratio (CNR) was plotted in 
the region of interest (ROI1) relative to the background (ROI2), in Figure 2(e), for each of the three cases 
at different depths of the object.    
Imaging Geometry: Radiation beam energies are carefully chosen to reach specific depths in the body, 
and a set of beams from different gantry angles can be delivered to the patient from these planned 
entrance positions.  In general, arbitrary angles and beam energies and dose values are chosen based 
upon an optimization algorithm to maximize dose to target regions and minimize dose to organs at risk 
of radiation damage. It is this flexibility of targeting which makes radiation-based excitation flexible for 
molecular imaging. The simplest angular geometries of orthogonal or lateral to the subject are shown in 
Figure 3(a) & (b), where the beam could be roughly orthogonal to the camera direction, for a sheet-like 
imaging, or aligned along it, for epi-illumination.  While the range of possible angles is much more than 
this, these were chosen as the extremes of signal to background, as will be shown. A complete analysis 
of the effect of geometry upon singular value index, matrix condition number and matrix rank, for the 
Jacobian to be inverted, is shown in the Supplementary Information section, Figure S3, using coefficient 
values listed in Table S.1.  
The experimental set up was photographed and is shown in Figure 3(c) and (d), and a single 
image of a single 1mm diameter capillary filed with 500PM PtG4, at 5mm depth into a tissue phantom 
solution is shown for each geometry in Figure 3(e) and (f), respectively. The phantom was a broad flat 
liquid media 200x200mm2, with the single luminescent capillary within it, and a scanned sheet beam was 
used to image with approximately 30 mGy per position of the beam. The color bar for each is the same 
and so the significantly higher background near 9,600 counts, leads to a contrast ratio of 1.14 and CBR 
value of 14% for the epi-illumination while the lower background near 2500 counts is seen for lateral 
illumination, leading to a contrast ratio of 3.5, and CBR of 220%. The higher background comes from the 
fact that the entire volume being imaged is being excited by Cherenkov, and so the signal comes from a 
mix of depths below the surface. Because of this observation, the lateral excitation geometry was used 
throughout most of the next experiments, providing a depth-selective excitation. A detailed analysis of 
the centroid position error and FWHM of recovered regions is shown in the Supplementary Information, 
in Figure S4  
Dose, Concentration & Depth of Imaging: The dominant factors affecting image recovery were 
explored systematically by varying one parameter at a time, as shown in Figure 4. The contrast to 
background ratio (CBR) was used as a metric of success, assessing how this varied with radiation dose 
delivered, concentration of PtG4 and depth of the object into the medium. The signal to background was 
defined as the ratio of the target relative to off the target. This figure of merit was chosen because CELSI 
is a background dominated imaging geometry, as are most luminescent and fluorescent imaging 
modalities [22]. CELSI of PtG4 in a 1mm diameter capillary was assessed with different concentrations, 
depths (distance from capillary to phantom surface) and radiation doses.  First using a fixed depth of 
5mm, the concentrations range was varied logarithmically from 500 PM down to 0.78 PM inside a 1mm 
capillary, measuring CBR for a 1 second acquisition time for dose of 0.1 Gy, with the overlapping 
excitation volume being 3.9x10-6L, making the number of moles used vary from 2.0 Pmol down to 3 nmol.  
The results are shown in Figure 4(a), being monotonic in shape and reducing to a CBR of 1 at about 6-8 
nmol.  Next the CBR was tracked for a fixed concentration of 500 PM in the 1mm capillary, for 200 nmol 
in the excitation volume, varying the depth down to 20mm into the phantom, also using 0.1 Gy dose, as 
shown in Figure 4(b).  This was monotonic with depth and appears to decrease near CBR=1 well beyond 
the 20mm depth.  Finally, the variation with radiation pulses added together was studied at a target depth 
of 5mm and fixed concentration of 100 PM, or 2 nmol, showing monotonic dependence on dose in Figure 
4(c), and decreasing to CBR of 1 at 2 radiation pulses, roughly equivalent to 1.67 mGy dose.    
Scan Directions and Tomographic Reconstruction: The direction and range of scan parameters in 
CELSI is quite large and three particular geometries were examined as analogous to other tomographic 
systems, and also to compare to fluorescence tomography systems. First a study of fluorescence 
tomography as acquired in the epi-illumination geometry was completed, as well as transmission 
geometry. For this 1% noise was randomly added to the simulated forward data with either a single 
embedded object or the 3 objects, as shown in Figure 5. The stopping criteria for the iterative 
reconstruction was when either a change in projection error of less than 0.01% was reached between 
iterations or at the maximum iteration number of 40 was achieved. A cartesian pixel basis is 30x30 
squares was used in Figure 5. These are shown in Figure 5(a) and (b) respectively with the test object 
shown, and reconstructed images in (d) and (e).  The CELSI tomography image with lateral excitation 
and vertical detection is shown in the schematic (c) and reconstructed object in (f).  In this case, CELSI 
is shown to be far superior to epi-illumination fluorescence tomography and higher contrast than 
transmission-based fluorescence tomography, and further numerical analysis of the Jacobian matrix 
improvement is shown in the Supplementary Information section, Figure S3.   
Next the range of possible scans available with CELSI was explored on how it would affect image 
recovery.  As shown in Figure 5(g)-(i), the horizonal, vertical and diagonal aspects of a scan can more 
fully interrogate the image space, and reconstructed images for these three respective geometries are 
shown in (j)-(l), with recovery from the combination of all of them shown in (m).  From these simulations 
it is obvious that the excitation line directions distort the recovered objects in the axial direction of the 
source-detector lines. As with all tomography applications, the larger the range of angles sampled, the 
better the image recovery can become, as shown in (m), better resolving the object in all directions. In 
this numerical study, only 3 angles were used, because it seemed sufficient to resolve the 3 objects, yet 
in principle an unlimited number of angles could be used, limited only by the added dose given to the 
subject. So as in CT imaging, ultimately there is a dose-resolution-contrast tradeoff which dictates the 
imaging system performance.  
Spatial Resolution: Both experiments and simulation studies were completed to assess the ultimate 
limits to spatial resolution with optimized conditions. The reconstruction set up and convergence criteria 
were the same as in the previous section, but a larger pixel basis of 100x100 pixels was used to improve 
quality of reconstructed images in Figure 6 (and Figure S4). Simulation studies were carried out with 
varying depths and using a standard resolution test, varying the distance between two small objects as 
illustrated in Figure 6(a). The reconstructed images are shown in with intensity in terms of the reconvened 
yield, as defined by the PtG4 absorption coefficient multiplied by the quantum yield of emission. The 
results reveal that when the depth of inclusions was smaller than 5mm, the CELSI tomography has the 
ability to discriminate the two inclusions with edge-to-edge distance of 0.1 mm, as plotted in Figure 6(b). 
When the depth of inclusions was increased to 2.5cm, the two inclusions can be also discriminated with 
edge-to-edge distance but nearer 0.5 mm. When the depth of inclusions was increased to 3 cm, the two 
inclusions can be also discriminated with edge-to-edge distance but nearer 1.8 mm. The results show 
that CELSI tomography can yield high spatial resolution, but that this spatial resolution does degrade with 
depth into the medium, as would be expected. These CELSI results can be compared to Epi-FT and Full-
FT results which have significantly lower spatial resolution, ranging from a few millimeters to beyond 
10mm at depth of 15 and 25 mm into the medium.  Figure 6(b) shows the minimum spatial resolution as 
a function of depth of inclusions. Epi-FT could not reconstruct the inclusions accurately when the depth 
of inclusions was deeper than 15 mm, therefore, the spatial resolution was not calculated.  
 Experimental studies were carried out to try and match the simulations but using a simpler 
geometry of a single capillary rod, positioned at 5mm into the tissue simulating phantom medium. A range 
of capillaries with diameters varying from 1mm down to 0.1mm were used with PtG4 at 50 PM filled in 
them.  The FWHM recovered was extracted and the observed FWHM is plotted against the true value in 
(d), showing nearly perfect linearity and matching the expected value of the smallest spatial resolution 
tested of 100 microns.   
Rodent & Phantom Imaging for Sensitivity & Resolution Testing: In order to verify that imaging in a 
complex tissue shape would be possible, the XFM-2 phantom was imaged with 1 mM PtG4 within 7 PL 
at the tip of the cylinder, for 7 nmol total PtG4, inserted into the central part of the body.  For these mouse 
phantom experiments, 35 radiation sheets were used, and the vertical step of each sheet was 
approximately 0.52 mm. The 3D forward simulation mesh contained 18496 nodes, 93818 elements and 
1712 boundary nodes, and the absorption and reduced scattering coefficients for excitation and emission 
were both set at Pa=0.007 mm-1 & Ps/=1.0 mm-1. The reconstruction pixel basis was 25x25x25 voxels. 
The initial guess of regularization parameter was 10, and the convergence criteria to stop the iterative 
update was when a change in projection error was less than 0.01% between successive iterations or 
when the maximum number of iterations was reached at n=10. The remitted luminescence image from 
above is shown in Figure 7(a) with the Cherenkov beam in the plane of the tube, with the luminescence 
from the tube showing a blurry image, with full width at half maximum (FWHM) of 10.4x11.9 mm in the 
two orthogonal directions. This signal is super imposed on the white light image of the mouse phantom. 
Reconstructed images are shown in the 3 orthogonal directions superimposed on CT scan images of the 
phantom (in grey scale).  This recovery showed good localization and recovery of the shape as might be 
expected, shown in Figure 7(b), with FWHM values of the reconstructed inclusion of 5.1x5.1x4.7mm in 
total.  Note that these dimensions are less than half of the FWHM values of planar projection imaging.  
 
To further advance and test the performance of CELSI reconstruction, an in vivo experiment with 
MDA-MB-231 tumors in a mouse was performed, with two tumors on the mouse hind limbs. The mouse 
was injected with 50 nmol of PtG4 into one tumor and 10 nmol into the other tumor, using a 50 PM stock 
solution. These doses were specifically chosen to be just above, and just below the detection threshold. 
Given the sizes of the tumors (9x9x6mm3|500mm3), these corresponded to approximately 0.4 nM and 
0.10 nM, when averaged over the tumor volume. The mouse was imaged within 30 minutes of injection. 
The other experimental setting was same as the phantom experiment. Figure 7(c) shows the CT scan of 
the animal, and (d) shows the acquired luminescent Maximum Intensity Projection image overlaid on the 
colorized CT scan, with this luminescence image showing very blurry localization, with FWHM of 18.9 x 
14.8 mm in the two orthogonal directions. The CT images were used to generate a finite element mesh, 
and the optical properties of tissues in the mouse were estimated by average homogeneous values for a 
mouse, based upon published values [17].   
 
For these in vivo experiments, the mouse was scanned with a sheet illumination procedure. A 
total of 19 irradiation sheets were used with a step between them of 0.8 mm. The forward simulation 
mesh contained 13185 nodes, 63852 elements and 3716 boundary nodes, and the absorption and 
scattering coefficients for excitation and emission were both set to Pa=0.01 mm-1 and Ps/=1.0 mm-1. The 
voxel basis for reconstruction was 25x25x25 pixels, and the initial guess of regularization parameter is 1. 
The convergence criteria was when the projection error changed by less than 0.01% between successive 
iterations or the maximum iteration number of n=10 was reached. Figure 7(e), (f) and (g) show the CELSI 
tomography reconstructed results from the 3 orthogonal views of the body interior, with reconstructed 
CELSI data in red. The FWHM values of the reconstructed CELSI image was 2.2x2.2x1.9 mm3.  Note 
that these dimensions were 7-8 times smaller than with planar imaging.  Thus, the tumor could be located 
accurately for the larger injected concentration, and the recovered size was substantially smaller than a 
with planar diffuse imaging, as is conventional for either epi-fluorescence or Cherenkov-excited 
luminescence imaging without a scanned source.  For the lower concentration tumor, the recovered 
regions were not visible above the noise level of the reconstructed image, illustrating the detection 
threshold was between 0.4 and 0.1 nM total agent in the scan volume at these tumor depths. The 
individual mouse shown is representative of the image quality and recovery possible within this 
concentration range, with a rotating view of the 3D volume in the Supplementary Information, video 1.  
 
Rodent Imaging for pO2 Sensing: A final murine experiment to map out pO2 was completed in mice 
with subcutaneous MDA-MB-231 tumors.  A total of 4 animals and 8 tumors were imaged (2 tumors per 
animal), with local injection of 50uL of 25uM PtG4, a total of 1.25 nmol per tumor. Each mouse was 
imaged while alive and the repeated at 30 minutes after sacrifice. Temperature was controlled using a 
heating pad, with alive mice at 35.1 +/- 1.5oC and dead mice at 31.9 +/- 1.2oC.  The CELSI scan was 
completed vertically for these cases, with the video 2 of the experimental data capture included in 
supplementary data.  Images of the luminescence at different delay times between linac pulse and 
emission captured are shown in Figure 8(a).  These were used for each mouse to create images of 
lifetime (b) and with the Stern-Volmer equation, the tissue pO2 (c). The summary of total lifetimes and 
pO2 values are shown in (d) and (e), respectively, as box & whisker plots. The entire range of values of 
alive versus dead to not overlap, indicating a significant difference in both lifetime and pO2 (p-value < 
0.001 for each).  But more importantly the range of values is +/-30% in lifetime, and +/-40% in pO2 value, 
as would be expected in heterogeneous tumors.  
 
Discussion 
Optical imaging of tissue has the potential for such rich molecular information but image recovery has 
been plagued by the scattering of light in tissue, making the signal non-linear and affected by tissue 
shape, optical properties, layers and regions, and often unacceptably low signal to noise with any 
appreciable depth into the tissue. CELSI is proposed here as a way to directly use high energy 
radiotherapy beams to launch light directly into the tissue, and by the knowledge of where the light was 
placed, it can allow high resolution recovery of luminescent sources.  While this approach to imaging has 
been introduced in just the past few years [10, 11], the factors that dictate the performance have not been 
exhaustively analyzed and non-linear tomography has not been applied to fully vet the imaging contrast 
recovery and spatial resolution. In this study, these issues have been fully examined and the capabilities 
of this type of imaging can now be established for pO2 imaging of tumors.  The value of a steered beam 
to provide localization of the excitation has inherent value to avoid organs at risk, and to multiplex the 
beam to multiple animals or multiple tissue volumes. The geometrical demonstrations of scanning 
explored in this study form the very basics of what can be done with a linac which is designed for highly 
conformal radiotherapy delivery.  
 The beam shape and angle of orientation have perhaps the largest effects upon the signal, with 
larger beam shapes having substantially larger signals and resulting contrast to background, as shown 
in Figure 3(d), presumably based upon the fact that the light scatters and builds up within the tissue.  
Additionally, there is an output factor for the beam which reduces with smaller beam sizes as well, and 
so while smaller or thinner beams provide the best spatial resolution, as shown in Figure 3, they inherently 
provide the lower signal intensities as well.  The direction of the beam relative to the camera, has perhaps 
the second most important factor, as a separation of the source from the surface being imaged inherently 
improves the observed contrast by suppressing background signals from surface tissues, as illustrated 
in the images of Figure 4. For these reasons, much of the work following these two initial studies focused 
around using the lateral beam geometry predominantly, and with a wide sheet of radiation, to maximize 
build up and light irradiance in the tissue.  It is this localization of the excitation beam which provides the 
inherent value of CELSI relative to isotope-based Cherenkov excitation studies[16, 23, 24].  In isotope-
based molecular sensing, the sensitivity can be as high, or even higher, down to the sub-nanomole range, 
but the ability to reconstruction and localize the emission is not dictated by anything other than the 
detected emission.  In CELSI imaging, the high precision beam knowledge, allows both deconvolution 
and depth-dependent attenuation correction, leaving a reconstructed signal which is highly localized in 
space to better than 1mm accuracy throughout the imaged volume of tissue.   
 Testing the key performance factors beyond these initial choices leads to a complex array of 
possible parameters.  The radiotherapy dose, the probe concentration and the depth into the tissue each 
contribute to the detected signal in ways which would have a reciprocity, as illustrated in Figure 4(d).  The 
imaging of luminescent targets is possible within the range of concentrations, doses and depths which 
are suitable for small animal imaging. The molecule number ranges near a PMolar are typical for 
metabolites and higher concentration receptors, and the ability to resolve uptake within many millimeters 
of tissue is a very important application in pre-clinical imaging. Within the volume of excitation, this 
corresponds to sensitivity needed near Pmol to nmol levels. Radiation doses used here have been in the 
range of x-ray exams, so while the concept of using a linear accelerator for imaging appears dangerous 
from a radiation safety perspective, it is critical to appreciate that this is done with very little dose delivered. 
Additionally, the radiation dose is selectively deposited to only where the scanned beam passes, so 
radiosensitive organs or dose limiting volumes could be strategically avoided in an optimized scan.  
 Perhaps the key observation in this work has been establishing the feasible spatial resolution 
several millimeters into the animal tissue for molecular sensing. This spatial resolution is largely dictated 
by the precision in which the x-ray beam can be controlled, because the signal origin can be localized to 
where the beam excited the luminescent agent. The imaging tests, both experimentally and 
computationally, support the belief that the spatial resolution is in the range of 100-300 microns for objects 
as deep as 5mm into the tissue.  Computationally this spatial resolution appears to be resolvable down 
to 20mm deep, and this fundamental limit is a fascinating goal for deep tissue imaging, essentially being 
able to achieve near microscopic resolution deep into tissue with optical imaging.  This realization is a 
fundamental breakthrough in molecular sensing in deep tissue.  
 Finally, the tests used with mouse phantoms and mouse tumors, both demonstrate the 
localization concepts and how the accuracy of reconstruction is superior to diffuse tomography or 
superficial MIP images of luminescence. This latter comparison to superficial imaging is important, 
because the vast majority of pre-clinical luminescent imaging is done with epi-illumination box systems 
where a single superficial surface image of the animal is achieved. Being able to bring optical imaging to 
a significantly higher whole body spatial resolution would have a profound impact for molecular imaging. 
The mouse phantom tested imaging in the geometry, size and average tissue optical property values of 
a mouse, showing excellent reconstruction of the embedded region. Then imaging in the heterogeneous 
tissues of a mouse is necessary since there are not realistic internal heterogeneities in the phantom. The 
more detailed CELSI images of tumor oxygenation as shown in Figure 9 illustrate how this methodology 
can be used to sense tumor pO2, and potentially do this with very high spatial resolution.  The features 
mapped out in this figure have sub-millimeter lateral spatial resolution, showing the heterogeneity of the 
pO2 ranging from 40-90 mmHg, as is known to be present in these tumors.  The heterogeneity seen 
within regions and between the tumors on the left and right presumably show areas of high and low pO2 
variation.  Areas that are high are presumably near major blood vessels and those with lower pO2 near 
areas distal from these, as would be expected, and tumors with overall higher values are usually more 
well perfused than those that tend to be hypoxic.  The ability to map pO2, pH and other features such as 
enzyme concentrations, protein expression, cell receptor density or metabolites would be valuable to 
understand responses to therapy.  This methodology will be most important for higher spatial resolution 
molecular features, where perhaps the tumor heterogeneity is a governing factor in response.        
In molecular imaging, there can be a separation between the imaging system’s physical 
capabilities and the pharmacokinetics and localization of the biochemical targeting moiety.  Yet, the value 
of a system is defined by the intersection of these two properties, where the physical resolution and 
contrast of the biochemical agent gets localized in biological features of the tissue. In the current 
realization of CELSI, the delivery was directly into solid tumors, avoiding the issue of plasma 
pharmacokinetics and tumor retention.  As such, the chosen focus here has been largely technological 
development, combined with localized delivery of the agent to tumors. While there are clear limitations to 
this, the approach does still match with radiotherapy delivery as well, where the location of delivery is 
well planned as targeted to the treatment volume.  As such, while the compound has its limitation at the 
site of injection, the knowledge of the oxygenation of these radiotherapy target sites is still of considerable 
value to radiation sensitization.  Thus, we present the application of localized oxygen sensing with high 
resolution CELSI in this format with clear potential to be further advanced by improvements in the 
biotargeting of luminescent reporters.  Recent studies have examined multiple agents for Cherenkov-
excited sensitivity with fluorescence [14, 20, 25], and for the capability of detecting multiple emitters at 
the same time [26]. Yet in all of these studies, PtG4 has been shown to be the most sensitive probe in 
terms of lower limit on concentration.  Also, with its design for oxygen sensitivity from quenching which 
is accessed by measurement of emission lifetime, it also provides one of the most practical tools for 
radiation therapy, where tissue oxygenation is known to be an important factor in therapy efficacy. 
However, there is also potential for other lifetime phosphor sensing agents such as pH [27, 28] 
 
Outlook 
Cherenkov Excited Luminescence Scanned Imaging (CELSI) allows pO2 imaging at a spatial resolution 
possible near 0.1mm through an intact living mouse, while utilizing nanomole levels of an oxygen 
sensitive biological probe in several mm of tissue. Cherenkov imaging initiated by x-ray beams from a 
linear accelerator can allow shaped thin sheets scanning in arbitrary directions, and by time-gating of the 
captured luminescence this process can allow for molecular sampling of a number of agents relevant to 
tissue microenvironment.  The depths and recovery possible are suitable for small animal imaging studies, 
and results from both computer simulations and experimental studies suggest that when fully automated, 
this type of imaging will have one of highest sensitivities and spatial resolutions for any pre-clinical whole 
body molecular imaging system.   
    
 
  
Methods 
LINAC & Cherenkov Imaging: Cherenkov was induced by a linear accelerator (Varian Linac 2100CD, 
Varian Medical System, Palo Alto, CA) based at the Norris Cotton Cancer Center, at Dartmouth-
Hitchcock Medical Center. The LINAC multi-leaf collimator (MLC) provided high flexibility in shaping the 
output beam to make arbitrary shaped treatment fields. Leaves are 5mm wide in this LINAC and oriented 
in many long thin sheets that are controlled to move in and out of the output beam and can be controlled 
to a level of 0.1mm precision. The effect of beam shape on the signal to background recovered acquisition 
was studied with radiation beam sizes using a larger square beam 100×100 mm2, a thin sheet beam of 
5×100 mm2, and a thin square pencil beam 5×5 mm2 with a vial of PtG4 of 5 µM in the phantom. CELSI 
of capillary containing PtG4 500 µM was studied with radiation beam sizes of 40×40 mm2 (epi-illumination) 
and 5×40 mm2 (lateral illumination). Background was acquired with acquisition 500 µs trigger delay.  Each 
of these were studied for epi-illumination imaging and then the thin sheet beam was also used for lateral 
sheet excitation, as will be shown, for optimal contrast.  To maximize signal and minimize background 
interference, the room lights were shut off throughout these studies, and all lights in the room were 
masked off with black cloth and black tape, as shown in the photographs.  
Luminescent Reporter & Tissue Phantoms: NIR fluorescent phosphorescent probe PtG4 Oxyphor [27] 
was prepared in standard 1x PBS at 500 μM concentration. This reporter has a strong oxygen sensitivity 
as described in previous work. [13, 14], as well as emission in the near infrared wavelengths, and 
excitation across the visible spectrum, matching Cherenkov excitation. Previous studies have examined 
the comparison of luminescence from phosphors and fluorophores form Cherenkov excitation, and in all 
studies, time-gated luminescence provides superior signal to noise, because of the superior background 
suppression provided by time-gating technology [25, 29, 30].   
The tissue simulating phantoms were prepared using 1% Intralipid© (Fresenius Kabi, Uppsala, 
Sweden). A capillary with 1 mm diameter of the probe at concentrations from 0.75 to 500 µM were placed 
inside the phantom at a depth which was varied between 2.5 to 20 mm from phantom surface being 
imaged. To study the dose efficacy for CELSI, the capillary containing the solution of the probe was 
irradiated with doses which varied from 360 pulses (approx. 5 Gy) down to 1 pulse (approx. 1.4 cGy) at 
500 µM concentration and 5 mm depth.  
Luminescence Imaging: The imaging system consisted of a time-gated intensified CCD camera (ICCD, 
PI-MAX4 1024i, Princeton Instruments, USA), a commercial lens (Canon EF 135mm f/2L USM), and a 
tripod mounted. The camera was focused on the imaging field approximately 1 meter away.  This distance 
was optimized through earlier studies where the signal to noise was found optimal, by moving back from 
the field, to avoid too much backscatter generated noise. The time-gated ICCD camera was synchronized 
to the radiation pulses (approximately 3.25 μs duration, 360 Hz repetition rate) with the intensifier set as 
×100 and turned on at a 3.5 μs or 500 μs gate delay following each radiation pulse for phosphorescence 
or background measurement, and luminescence generated during 50μs gate width was integrated via 
this ICCD. The display of images in emission were originally captured in counts per pixel, as read from 
the camera, and this has been calibrated to photons/mm2/s by calibration of the number of photons 
detected per count, which was previously studied and found to be 95 counts read out at the CCD per one 
photon incident upon the ICCD photocathode. Similarly, the camera has 13x13 Pm2 pixels, and so this 
was converted from pixels to a mm2 units.    
Initial experiments focused on examining the signal to background issue, using a single 1mm 
inner diameter glass capillary tube (Hampton Research Corp, Glass number 50 capillaries, Aliso Viejo 
CA), filled with 500 microMolar PtG4, and imaging with the linac vs camera in two different geometries, 
as shown in Figure 3.  In the vertical scan direction (also sometimes called epi-illumination geometry), 
where the linac and camera have the same perspective, higher background would be expected due to 
the high Cherenkov at the surface of the phantom, shown in Figure 3(c).  Whereas when the linac beam 
was orthogonal to the camera direction, then Cherenkov is not produced at the surface, and background 
would expect to be lower as viewed by the camera, shown in Figure 3(d).  These studies were carried 
out to experimentally verify this with a single capillary image.  
Factors Affecting Contrast: Dose, Concentration, Depth: The signal contrast in all imaging systems 
is a function of key parameters and so for CELSI it was hypothesized that these key factors would be 
linearly related to the radiation dose used, the concentration of probe present in the tissue, and the 
logarithm of the depth in which the target was located. The depth dependence on signal is likely more 
complex because of the light diffusion process, but might be expected to fall off over macroscopic 
distances with the effective attenuation coefficient of the medium, estimated by diffusion theory to be Peff 
= (3PaPs/)1/2, where Pa is the absorption coefficient and Ps/ is the transport scattering coefficient of the 
tissue. The dose delivered was varied by simple linear summation of the signal over more LINAC pulses, 
to effectively build up signal with delivered dose.  The concentration of PtG4 was varied in solution within 
the embedded object, from 500 PM down to 0.78 PM using a 1mm capillary present at 5mm depth into 
the medium.  The excitation volume of this was given by the overlap of the 5mm beam with the 1mm 
capillary, which was V = 𝛑 r2 h = 3.9x10-6 L.  
 The signal to background ratio was used as a metric of recovered accuracy in this study, with the 
simple calculation defined by the ratio of the average intensity values: 
𝑆𝑖𝑔𝑛𝑎𝑙 𝑡𝑜 𝐵𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑 =  < 𝐼𝑅𝑂𝐼 >< 𝐼𝐵 >  
Where IROI Is the mean pixel intensity in the region of interest (ROI) and the IB is the mean pixel intensity 
in the background, outside the ROI. In some studies, the contrast to noise ratio was used as a metric, 
which was defined as: 
𝐶𝑁𝑅 =  < 𝐼𝑅𝑂𝐼 >  − < 𝐼𝐵 >σB  
Where VB was defined as the standard deviation of intensities in the background region.  
Spatial Resolution Assessment: The spatial resolution of imaging was assessed with a range of glass 
capillary tubes of varying inner diameter, from 0.1mm up to 1.0mm (Hampton Research Corp, Glass 
number 50 capillaries, Aliso Viejo CA).  These tubes were placed into tissue simulating phantom at 5mm 
depth one by one, and all were filled with 50 PM PtG4 to provide a high contrast target for resolution 
assessment.   The sheet radiation beam was scanned laterally across the tube, to vary the signal with 
position, and the linescan full width at half maximum (FWHM) was recovered for each capillary 
experiment.    
Computed Tomography Recovery: CELSI data can be scanned for different beam angles and the 
performance expected varies considerably based upon these choices.  The range of options is so large 
that experimental study of these is prohibitive, and so a series of computer simulations were carried out, 
in particular to compare CESLI images to diffuse fluorescence tomography images where traditional light 
excitation is used as compared to Cherenkov excitation.  Additionally, different combinations of scanning 
angles and different depths and sizes of objects could be simulated much more quickly than carrying out 
all the experiments.  The computer simulations were carried out in the NIRFAST software package 
(available at www.nirfast.org), used to model light transport in tissue, and carry out regularized iterative 
reconstruction of the luminescent reporter in the medium. The recovery of the reporter was in terms of 
units of luminescent yield, KPaf, where K is the reporter quantum yield for phosphorescence emission and 
Paf is the absorption coefficient of the reporter (see Supplementary Information for further explanation of 
the theory). This quantity is a direct report of the amount of light produced per unit volume. To assess 
spatial resolution of CELSI tomography, a classic resolution test was performed with two small inclusions 
and varying the spatial distance between them and assessing when they could not be resolved as 
separate objects. The edge-to-edge distance was varied from 0.1 mm to 5 mm, in the plausible range of 
limiting spatial resolutions given the physical constraints of the LINAC MLCs used. The yield contrast of 
inclusion was set as 10:1. A finer mesh with 6161 nodes and 12000 linear triangular elements was used 
in reconstruction. Inspired by the results of combining of scan modes, the following reconstructions were 
performed by summing up scan modes.  
Animal Phantom Imaging: In order to assess performance in a more complex tissue geometry, a 
commercially available mouse phantom was used (Xfm-2, PerkinElmer Health Sciences, Waltham MA), 
using rod of material inserted which was filled with 1 mM PtG4, in 7 PL (7 nmol). This phantom has tissue 
optical properties within the NIR wavelengths 650-800nm, approximated by Pa=0.003-0.008 mm-1 and 
Ps/=1.5-0.9 mm-1 (manufacturer supplied data sheet). This phantom was crated for phantom studies which 
would allow imaging in a realistic tissue volume and geometry that directly mimics the shape and 
absorption and reduced scattering coefficient values representative of murine tissue. The CELSI imaging 
was carried out with lateral beam excitation and vertically oriented emission capture, using a long lifetime 
gate on the camera, to sync out the Cherenkov light and noise, and maximize luminescence emission 
detection. X-ray tomography was completed on the IVIS Spectrum CT (PerkinElmer Inc, Hopkington MA) 
with the full field of view 120x120x30mm3, with a 150 Pm voxel scan acquired in 90 seconds.  
Tumor Cell Lines: MDA-MB-231 cells were purchased directly from ATCC as a confirmed cell type and 
mycoplasma free, no further testing was performed, and the cells lines are not listed in the ICLAC 
database of cross-contaminated or misidentified cell lines. Cells were grown in culture media in an 
incubator at 37oC in DMEM with 10% (v/v) Fetal Bovine Serum (FBS) and 1% penicillin-streptomycin. 
When ready for use, cells were trypsonized, counted, spun down into a slurry, and used for inoculation 
into animals.  
Animal Studies: All animal procedures were approved by the Dartmouth Institutional Animal Care and 
Use Committee, and the studies here were carried out in compliance with these approved procedures. 
Nude female mice were purchased at 6 weeks of age from Charles River Labs. After a week of 
acclimatization, animals were used for injections of 105 cells under the skin on each flank of the mouse 
in individual 0.050 mL injections. After approximately 3 weeks of growth, when a tumor with an average 
of 6mm diameter tumor was observed on both flanks, then the animals were used for imaging studies. 
All mice were under general anesthesia of inhaled isofluorane at 1.5% in flowing air through a nose cone 
throughtout imaging.  For the tomography study, to demonstrate the detection level, a total of 0.5ml of 
PtG4 was directly injected into the tumors of a mouse, with one concentration of 50 nmol into one tumor 
and 10 nmol into the other tumor. This animal was imaged by 3D CELSI tomography at 30 minutes after 
injection, and then again imaged in the IVIS Spectrum CT system for x-ray tomography.  The x-ray scan 
utilized 50 kVp standard 150 micron resolution imaging of the mouse in a 12x12x3cm3 field size.  In 
further pO2 imaging studies, a cohort of 4 mice were used with a tumor in each flank (2 tumors per mouse, 
for n=8 tumors) and used for imaging when the average dimension diameter was 6mm as measured over 
the two orthogonal axes.     
Statistical Analysis: The differences between the alive and dead conditions, as displayed in Figure 8, 
with n=8 paired samples each was established by a two tailed students t-test, with alpha=0.05, and 
resulting p-value < 0.001.  These indicate that both in lifetime as well as pO2, there are significant 
differences between the values of the animals in the two conditions. However more pertinent to the value 
of the study is the observation of the total range of values, presented as a % of the median value. The 
figures 8(d) & (e) were generated using Python 3.4.3 with the library matplotlib 2.0.0. The function used 
to make the box plot is called boxplot available at this link: 
(https://matplotlib.org/api/_as_gen/matplotlib.pyplot.boxplot.html). The box extends from the lower to the 
upper quartile values of the data, with a line at the median. The whiskers extend from the box to show 
the range of the data. Flier points are those past the end of the whiskers.   
Data Availability: Datasets generated and analyzed during the current study are available from the 
corresponding author upon email request. All data generated or analyzed during this study are included 
in this published article (and its supplementary information files).  
Code Availability: Image reconstruction code was custom developed for this study, and is available for 
download in bulk through our website www.nirfast.org, and individual MATLAB routines are available 
from the corresponding author.  
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Figure Captions 
Figure 1. A comparison of the excitation fluence loss with depth into tissue for (a) laser/LED excitation 
and (b) Cherenkov excitation generated within the tissue from a LINAC radiation beam. The diagram of 
the experimental setup is shown (c) with measurement devices. In (d) a raster scan approach to image 
measured by the ICCD is shown with gated emission detected by a spectrometer system.  In (e) the 
absorption and (f) the luminescence emission spectra are shown for PtG4, with peak wavelengths labeled, 
and overlaid with the Cherenkov spectrum (blue) from single solution scans. The structure of PtG4 is 
illustrated in the Supplementary Information, Figure S2. 
Figure 2. The configuration of the radiation beam shape and region of the tissue where Cherenkov would 
be generated by a (a) single broad beam throughout the 3D volume of the animal, or (b) in a 2D sheet 
beam, or (c) in a 1D pencil beam. These geometric choices each affect the signal to noise possible with 
CELSI, and hence the sensitivity of other parameters such as minimum concentration and depth of 
imaging feasible and acquisition time. Images of the field light, Cherenkov emission on a phantom and 
the luminescence from a single square target in the phantom are shown in (d) for the geometries in (a)-
(c), with duplicate images taken in separate imaging sessions showing nearly identical image quality.  
The contrast to noise ratio (CNR) of the target relative to the background is shown in (e) as measured by 
individual scans, where each data point represents an individual acquisition.  The units for the color bars 
on images in (d) and inset in (e) are in detected photons/cm2/s and a 1cm scale bar is in the bottom right 
corner of each panel. 
Figure 3. The geometry of imaging camera relative to X-ray beam entrance position is shown in (a) an 
vertical (or epi-illumination) scan, and (b) a lateral sheet scan. Photographs of the LINAC-camera set up 
for (c) vertical and (d) orthogonal camera and LINAC beam, similar to schematics (a) and (b). Single 
frame images of PtG4 luminescence from one capillary within a broad tissue phantom are shown in (e) 
and (f) for these geometries, respectively, with color bars on the same scale for the two representing the 
full range available on the camera. These representative single images illustrate the high background 
and hence poorer contrast from the epi-illumination geometry, as seen from an individual snapshot. The 
signal to background values are 15% for (e) and 220% for (f) above the background level. The units for 
the color bars on images in (e) and (f) are in detected photons/cm2/s and 5mm scale bar is shown in the 
bottom right of each panel. 
Figure 4. Signal to background ratio measurements from PtG4 contained within a 1mm capillary with (a) 
different concentrations in the physiologically relevant range, (b) varying depth between the capillary wall 
to the surface of the phantom being imaged, and (c) varying radiation dose between 1 and 500 radiation 
pulses, with 1.67mGy/pulse. In each graph, the line scan raw data is inset. Each individual data point 
represents extraction of signal to background for a single scan of a test object, with varying conditions as 
shown in the x-axes. The red lines in each graph illustrate the linear trendline of the data on the log-log 
plots.  In (d) the factors affecting CELSI signal strength are schematically illustrated as being reciprocal 
in their effect upon signal to background, illustrated by the red lines of constant value. 
Figure 5.  Source and detector placement used for (a) the Epi-fluorescence tomography (Epi-FT), (b) the 
Full-FT, and (c) the lateral excitation CELSI with tomographic reconstruction. The blue arrows represent 
the source locations, and the red arrows denote the detector locations. Reconstructed luminescence 
distributions corresponding to the three geometries shown in Figure 2(a)-(c), for (d) the Epi-FT, (e) the 
Full-FT, and (f) the CELSI. Three angles of scanning for CELSI were examined as illustrated in (g) – (i), 
for horizonal, vertical and diagonal, respectively, and three test objects at different depths were used as 
a test field for this, with reconstructions as shown in (j) – (l). The combined set of all 3 scan geometries 
was used for the reconstructed image (m), showing the best preservation of the three objects space and 
intensities with 30 iterations in each reconstruction.  These simulations were carried out once for each in 
individual graph shown.  
Figure 6. To establish the theoretical limits to spatial resolution, reconstructed results using CELSI 
tomography are shown in units of luminescent yield, KPaf, in the colorbar, for two inclusions with varied 
edge-to-edge distance in different depths are shown, (a).  The white scale bar in the bottom right is 30 
mm. These simulations were carried out once for each location of the pair of 5mm diameter, 50 PM PtG4, 
inclusions. At each depth, the minimum resolvable distance was estimated and plotted in (b), for epi-
illumination fluorescence tomography, diffuse fluorescence tomography, and CESLI tomography.  
Capillaries filled with PtG4 are shown (c) varying from 0.1mm diameter up to 1.0 mm diameter, and were 
embedded into a tissue equivalent phantom, and a sheet beam scanned laterally to extract the FWHM 
for each sized tube (d).  Each data point reports a single measurement, and fitting was completed with 
r2>0.9 for each sample.  
Figure 7. The phantom experiments shown as measured once. (a) The luminescent yield images are 
overlaid on the top surface of the microCT image, in colorbar units of photons/cm2/s, and the 
reconstructed images shown with 3 orthogonal views, axial (b), sagittal (c) and transverse (d) with the 
colorbar reporting values for (b)-(d) in units of KPaf. The in vivo imaging study is shown from a single 
animal, with an x-ray CT scan and a summed intensity projection image of the luminescence overlaid on 
the color-coded CT scan (e) in colorbar units of photons/cm2/s. Then CELSI tomographic data is overlaid 
on the high resolution microCT images for axial (f), sagittal (g) and 3D perspective (g) views of the 
reconstruction. The location of the two MDA-MB-231 tumors grown on the hind flanks are shown by 
arrows, with 50 nmol PtG4 injected into the tumor with a blue arrow, and 10 nmol PtG4 was injected into 
the tumor with the orange arrow, and the entire body of the animal was scanned and reconstructed with 
CELSI. The reconstructed image shows recovery of the high concentration injection while the lower 
concentration injection is not recovered, to illustrate the detectable limit is in the range of tens of 
nanomoles. (A full rotating 3D video of this mouse is available in the Supplementary Information, Section 
S.7) 
Figure 8. Nude mice with subcutaneous breast adenocarcinomas (MDA-MB-231) were injected with 
50uL of 25uM PtG4 in each tumor and imaged. In (a) Maximum intensity projection (MIP) images of 
CELSI are shown with increasing delays after radiation pulse, with color bar in photons/cm2/s, and (b) 
the pixel-wise lifetimes (𝜏) estimated alive, and after sacrifice as a low pO2 control. These were used to 
(c) calculate pO2 maps via the Stern-Volmer relationship.  In (d) box-plots show lifetime estimates for all 
tumors (n=8), and (e) shows the calculated pO2 estimates for these (n=8). Measurement scans were 
acquired once for each animal. (A video of a single scan sequence is available in the Supplementary 
Information, Section S.7).  
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